(Q37826657)

23 August 2017

1 reference

title

Navigating risk stratification systems for the management of patients with GIST. (English)

1 reference

23 August 2017

0 references

Shreyaskumar Patel

1

1 reference

23 August 2017

publication date

7 January 2011

1 reference

Annals of Surgical Oncology

23 August 2017

published in

1 reference

23 August 2017

volume

18

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

1698-1704

1 reference

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Management of malignant gastrointestinal stromal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Clinical manifestations and prognostic factors in patients with gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Biology of gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Molecular pathobiology of gastrointestinal stromal sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncol

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Risk stratification of patients diagnosed with gastrointestinal stromal tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Approval summary: imatinib mesylate in the adjuvant treatment of malignant gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Gastrointestinal stromal tumours (GIST) - 17 years experience from Mid Trent Region (United Kingdom).

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1496-Z

10.1245/S10434-010-1496-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

23 August 2017

1028394070

0 references

1 reference